Cargando…
EPR-mediated tumor targeting using ultrasmall-hybrid nanoparticles: From animal to human with theranostic AGuIX nanoparticles
Interest of tumor targeting through EPR effect is still controversial due to intrinsic low targeting efficacy and rare translation to human cancers. Moreover, due to different reasons, it has generally been described for relatively large nanoparticles (NPs) (hydrodynamic diameter > 10 nm). In thi...
Autores principales: | Bort, Guillaume, Lux, François, Dufort, Sandrine, Crémillieux, Yannick, Verry, Camille, Tillement, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956799/ https://www.ncbi.nlm.nih.gov/pubmed/31938067 http://dx.doi.org/10.7150/thno.37543 |
Ejemplares similares
-
AGuIX(®) from bench to bedside—Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine
por: Lux, François, et al.
Publicado: (2019) -
Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma
por: Thomas, Eloïse, et al.
Publicado: (2017) -
Functionalization of theranostic AGuIX® nanoparticles for PET/MRI/optical imaging
por: Thakare, Vivek, et al.
Publicado: (2019) -
Multiscale Selectivity and in vivo Biodistribution of NRP-1-Targeted Theranostic AGuIX Nanoparticles for PDT of Glioblastoma
por: Gries, Mickaël, et al.
Publicado: (2020) -
AGuIX nanoparticles as a promising platform for image-guided radiation therapy
por: Detappe, Alexandre, et al.
Publicado: (2015)